On Nov. 5, 2020, RELIEF THERAPEUTICS and NeuroRx announced that the independent Data Monitoring Committee (DMC) voted unanimously…
On Nov. 5, 2020, Regeneron announced an update from the independent data monitoring committee (DMC) for the UK-based…
On Nov. 5, 2020, Neoleukin Therapeutics announced the publication in Science of research describing novel molecules designed to…
On Nov. 4, 2020, the University of Oxford announced that its rapid COVID-19 test was being used at…
On Nov. 4, 2020, scientists at the University of Oxford announced they had discovered that obesity can increase…
On Nov. 4, 2020, Humanigen announced positive interim Phase 3 data of lenzilumab in patients hospitalized with COVID-19….
On Nov. 4, 2020, using the cutting-edge genetic editing technique known as CRISP ﾓlab on a chipï¾” technology,…
On Nov. 3, 2020, NIAID researchers and colleagues announced they had discovered a mechanism that some bacteria, such…
On Nov. 2, 2020, CureVac announced positive interim data from its ongoing Phase 1 dose-escalation study evaluating the…
On Nov. 2, 2020, Innovation Pharma announced receipt of written feedback from the FDA that is in general…
On Nov. 2, 2020, Immunic announced that the company had enrolled and randomized 200 patients, pre-specified in the…
On Nov. 2, 2020, Walgreens Boots Alliance (WBA) and McKesson announced the completion of their previously announced agreement…
On Nov. 2, 2020, ACON Laboratories announced the launch of its Flowflexï¾™ SARS-COV-2 Antigen Rapid Test. The Flowflex…
On Oct. 31, 2020, the U.S. Department of Health and Human Services (HHS) announced that 389,040 state-of-the-art Abbott…
On Oct. 31, 2020, the U.S. Department of Health and Human Services and the U.S. Department of Defense…
On Oct. 30, 2020, the Centers for Disease Control and Prevention (CDC) issued a Framework for Conditional Sailing…
On Oct. 30, 2020, the University of Oxford announced that Kenya had joined the global efforts in search…
On Oct. 30, 2020, Humanigen announced that MedStar Washington Hospital Center in Washington, D.C. treated its first COVID-19…
On Oct. 30, 2020, Hologic announced that it had been awarded a $119 million contract from the U.S….
On Oct. 30, 2020, Innovation Pharma and George Mason University jointly announced completion of extensive laboratory testing supporting…
On Oct. 30, 2020, Regeneron announced that ot had received a recommendation from the independent data monitoring committee…
On Oct. 30, 2020, Icosavax announced the launch of the companyï¾’s COVID-19 vaccine program with preclinical data on…
On Oct. 30, 2020 InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
On Oct. 29, 2020, the Centers for Disease Control and Prevention (CDC) opened its new South America regional…
On Oct. 29, 2020, the University of Oxford announced a new pilot scheme to assess the use of…
On Oct. 29, 2020, Mammoth Biosciences announced that it had signed agreements with MilliporeSigma and Hamilton Company targeting…
On Oct. 29, 2020, OncoSec Medical announced that the FDA had approved the Investigational New Drug (IND) application…
On Oct. 29, 2020, Humanigen announced that the first patient had been dosed at the Emory University School…
On Oct. 29, 2020, PerkinElmer announced that the FDA had issued Emergency Use Authorization (EUA) to allow sample…
On Oct. 29, 2020, Emulate announced that it had entered into a Cooperative Research and Development Agreement (CRADA)…